Filing Details

Accession Number:
0001870278-23-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-06 16:29:25
Reporting Period:
2023-01-05
Accepted Time:
2023-01-06 16:29:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870278 Alexander Michael Smith 700 Us Highway 202/206
Bridgewater NJ 08807
General Counsel, Senior Vp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-05 720 $19.72 49,836 No 4 S Direct
Common Stock Acquisiton 2023-01-05 6,332 $0.00 56,168 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2023-01-05 29,050 $0.00 29,050 $19.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,050 2033-01-05 No 4 A Direct
Footnotes
  1. Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  2. Includes 101 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  3. Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.
  4. Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.
  5. Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.